Blueprint is also eligible to receive up ... and Taiwan), where it has a partnership with CStone Pharmaceuticals. In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil ...

Chairman of Egyptian Pharmaceutical City Amr Mamdouh said that Egypt has all the necessary qualifications to pioneer in the pharmaceutical localization field and enhance local production ...

J.P. Morgan said its top biotech picks for 2025 were Vertex, Travere, SpringWorks, PTC Therapeutics, Wave Life Sciences, ...

In 2023, the FDA approved Blueprint Medicines’ Ayvakit (avapritinib) as the first, only treatment for indolent systemic mastocytosis (ISM). In the third quarter of 2024, Ayvakit reported net ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Steris (STE – Research Report), Benitec ...